Digital health case studyPharmaceutical
Tracking Competitor Moves to Support Global Franchise Strategy
Client context: Top 10 global pharmaceutical company
Strategic question
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Decision enabled
What the client could do next
Enabled leadership to make faster, more defensible portfolio and competitive-response decisions across core franchise areas.
Approach
Using HealthTech Alpha’s structured intelligence layer, Galen Growth tracked five priority competitors across the US, EU5, UK, China and adjacent markets over a 12-month programme. We delivered curated alerts, bespoke workspaces and bi-monthly executive decision memos to create a consistent view of competitor movement.
Methodology
Strategic interpretation
Leadership gained a traceable, source-grounded view of competitor activity across priority therapeutic areas and geographies, reducing fragmented signal and improving cross-franchise alignment.
